Cargando…
Molecular Mechanism of Thiazolidinedione-Mediated Inhibitory Effects on Osteoclastogenesis
Thiazolidinediones are synthetic peroxisome proliferator-activated receptor γ agonists used to treat type 2 diabetes mellitus. Clinical evidence indicates that thiazolidinediones increase fracture risks in type 2 diabetes mellitus patients, but the mechanism by which thiazolidinediones augment fract...
Autores principales: | Zhao, Dongfeng, Shi, Zhenqi, Warriner, Amy H., Qiao, Ping, Hong, Huixian, Wang, Yongjun, Feng, Xu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102552/ https://www.ncbi.nlm.nih.gov/pubmed/25032991 http://dx.doi.org/10.1371/journal.pone.0102706 |
Ejemplares similares
-
Retraction: Molecular Mechanism of Thiazolidinedione-Mediated Inhibitory Effects on Osteoclastogenesis
Publicado: (2020) -
Thiazolidinedione-Induced Fluid Retention: Recent Insights into the Molecular Mechanisms
por: Bełtowski, Jerzy, et al.
Publicado: (2013) -
The molecular mechanism of osteoclastogenesis in rheumatoid arthritis
por: Udagawa, Nobuyuki, et al.
Publicado: (2002) -
Niclosamide and its derivative DK‐520 inhibit RANKL‐induced osteoclastogenesis
por: Jiao, Yurui, et al.
Publicado: (2020) -
Chemotherapy and Chemoprevention by Thiazolidinediones
por: Fröhlich, Eleonore, et al.
Publicado: (2015)